Publications and Abstracts
Please see below a selection of scientific publications and presentations about EndoBarrier® Therapy, GI Dynamics' breakthrough treatment for type 2 diabetes and obesity.
2013
"A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes." Cohen RV, Neto MG, Correa JL, Sakai P, Martins B, Schiavon CA, Petry T, Salles JE, Mamedio C, Sorli C. J Clin Endocrinol Metab. 2013 Feb;98(2):E279-82.
"Endoscopic Duodenal-Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes." de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, le Roux CW, Schaper NC, Bouvy ND, Greve JW. Obes Surg. 2013 Mar 23. [Epub ahead of print]
2012
"Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal–Jejunal Bypass Liner.” Diabetes Technology & Therapeutics, 2012. E. G.H. de Moura, B. C. Martins, G. S. Lopes, I. R. Orso, S. L. de Oliveira, M. P. Galvão Neto, M. A. Santo, P. Sakai, A. C. Ramos, A. B. Garrido Júnior, M. C. Mancini, A. Halpern, I. Cecconello.
“Six month results of a multi-center, prospective, randomized trial of the endoscopic Duodenal-Jejunal Bypass Liner for the treatment of type 2 diabetes in obese subjects.” Presented at the American Diabetes Association (ADA) 72nd Scientific Sessions, 2012. P. Koehestanie, B. Meesters, I.M.C. Janssen, N. Bouvy, J.W. Greve.
“Mechanisms for improved glycemic control after endoscopically placed Duodenal-Jejunal Bypass Liner.” Presented at the American Diabetes Association (ADA) 72nd Scientific Sessions, 2012. R.V. Cohen, C.W. le Roux, D. Papamargaritis, J. Salles, T. Petry, J.L. Correa, M.G. Neto, B. Martins, P. Sakai, C.A. Schiavon, C. Sorli.
"Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year With an Endoscopic Duodenal-Jejunal Bypass Liner." Annals of Surgery, 2012. A. Escalona, F. Pimentel, A. Sharp, P. Becerra, M. Slako, D. Turiel, R. Mun ̃oz, C. Bambs, S. Guzma ́n, L. Iba ́n ̃ez, and K. Gersin."
“Isolated Duodenal Exclusion Increases Energy Expenditure and Improves Glucose Homeostasis in Diet-induced Obese Rats.” Am J Physiol Regul Integr Comp Physiol, 2012. R. Muñoz, J.S. Carmody, N. Stylopoulos, P. Davis, L.M. Kaplan.
“Implantation of the duodenal-jejunal bypass sleeve under conscious sedation: a case series.” Surgery for Obesity and Related Diseases, 2012. R. Montaña, M. Slako, A. Escalona.
2010
"Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery” Gastrointestinal Endoscopy, 2010. K Gersin, R Rothstein, R Rosenthal, D Stefanidis, S Deal, T Kuwada,W Laycock, G Adrales, M Vassiliou, S Szomstein, S Heller, A Joyce, F Heiss, D Nepomnayshy.
“Initial Human Experience with a Restrictive Duodenal- Jejunal Bypass Liner for the Treatment of Morbid Obesity.” Surgery for Obesity and Related Diseases, 2010. A Escalona, R Yanez, F Pimentel, M Galvao, A Ramos, D Turiel, C Boza, D Awruch, K Gersin, L Ibanez.
2009
“Pilot Clinical Study of an Endoscopic, Removable Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes.” Diabetes Technology and Therapeutics, November 2009. L Rodriguez, E Reyes, P Fagalde, M Oltra, J Saba, C Aylwin, C Prieto, A Ramos, M Galvao, K Gersin, C Sorli.
2008
“First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve.” Surgery for Obesity and Related Diseases, 4 (2008): 55-59. L Rodriguez, M Galvao, M Alamo, A Ramos, P Brante, M Tarnoff.
“An Endoluminal Sleeve Induces Substantial Weight Loss and Normalizes Glucose Homeostasis in Rats with Diet-Induced Obesity.” Obesity (2008) 16 12, 2585–2592. doi:10.1038/oby.2008.502. V Aguirre, N Stylopoulos, R Grinbaum, L M Kaplan.
